♥
ISIN : INE019C01026
NSE : HSCL
BSE : 500184
Face Value : 1
Industry : Chemicals
EPS : 9.16
EPS (TTM) : 10.08
Price to Earning (P/E) : 46.33
Book Value : 61.80
Price to Bookvalue (P/B) : 6.87
Dividend Yield : 0 %
Return on Equity (ROE) : 15.74 %
Return on Capital Employed (ROCE) : 18.86 %
Himadri Speciality Chemical Limited
ISIN : INE019C01026
NSE : HSCL
BSE : 500184
Face Value : 1
Industry : Chemicals
EPS : 9.16
EPS (TTM) : 10.08
Price to Earning (P/E) : 46.33
Book Value : 61.80
Price to Bookvalue (P/B) : 6.87
Dividend Yield : 0 %
Return on Equity (ROE) : 15.74 %
Return on Capital Employed (ROCE) : 18.86 %
Himadri Speciality share price(02-Apr-2026) | |
|---|---|
| Open / Close | 0 - 0 NAN % |
| Low / High | 0 - 0 NAN % |
| Trade Volume | 0 |
| 52 Week Low / High | 0 - 0 NAN % |
| Open / Close | 436.1 - 448.25 2.8 % |
| Low / High | 428.05 - 450.85 5.3 % |
| Trade Volume | 2.37 Lk |
| 52 Week Low / High | 407.05 - 534.35 31.3 % |
-
YOU MAY ALSO LIKE
- CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - Stock market course tutorial
Stock Market Investment Course explained in simple words. - Share Market basics for beginners
Share Market jargons in simple terms
CONSOLIDATED QUARTERLY RESULT FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| Date End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 10466.4 | 10589.1 | 10373.9 | 10289 | 9509.1 | 10045.2 | 10525.1 | 11769.5 | 12004.1 | 11369.2 |
| Total Income | 10482 | 10671 | 10450.6 | 10394.5 | 9610.3 | 10143.4 | 10627 | 11893.4 | 12130.5 | 11504.9 |
| Total Expenditure | 9750.4 | 9617.7 | 9324.9 | 9033.4 | 8169 | 8468.6 | 8786.1 | 9974.5 | 10084.9 | 9287.9 |
| Other Income | 15.6 | 81.9 | 76.7 | 105.5 | 101.2 | 98.2 | 101.9 | 123.9 | 126.4 | 135.7 |
| Operating Profit | 731.6 | 1053.3 | 1125.7 | 1361.1 | 1441.3 | 1674.8 | 1840.9 | 1918.9 | 2045.6 | 2217 |
| Interest | 126.5 | 199.7 | 202.5 | 132 | 131.5 | 159.5 | 212.2 | 135.5 | 129.5 | 113 |
| Exceptional Items | -300 | |||||||||
| PBDT | 605.1 | 553.6 | 923.2 | 1229.1 | 1309.8 | 1515.3 | 1628.7 | 1783.4 | 1916.1 | 2104 |
| Depreciation | 126.1 | 130.7 | 128.5 | 123.2 | 121 | 124.3 | 127.2 | 126.1 | 129.3 | 131 |
| Profit Before Tax | 479 | 422.9 | 794.7 | 1105.9 | 1188.8 | 1391 | 1501.5 | 1657.3 | 1786.8 | 1973 |
| Tax | 93.4 | 64.1 | 142.6 | 343.8 | 327.8 | 384.8 | 413.7 | 505.5 | 559 | 616 |
| Profit After Tax | 385.6 | 358.8 | 652.1 | 762.1 | 861 | 1006.2 | 1087.8 | 1151.8 | 1227.8 | 1357 |
| Net Profit | 385.6 | 358.8 | 652.1 | 762.1 | 861 | 1006.2 | 1087.8 | 1151.8 | 1227.8 | 1357 |
| Equity Capital | 419.3 | 419.3 | 419.4 | 432.7 | 439 | 440 | 440.7 | 492.6 | 493.5 | 493.7 |
| Face Value (IN RS) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Calculated EPS | 0.92 | 0.86 | 1.55 | 1.76 | 1.96 | 2.29 | 2.47 | 2.34 | 2.48 | 2.74 |
| Diluted Eps After Extraordinary Items | 0.92 | 0.86 | 1.55 | 1.8 | 1.99 | 2.29 | 2.47 | 2.41 | 2.48 | 2.72 |
| Diluted Eps Before Extraordinary Items | 0.92 | 0.86 | 1.55 | 1.8 | 1.99 | 2.29 | 2.47 | 2.41 | 2.48 | 2.72 |
STANDALONE QUARTERLY RESULT FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| Date End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 10466.4 | 10589.1 | 10373.9 | 10289 | 9509.1 | 10045.2 | 10525.1 | 11769.5 | 11997.7 | 11352.1 |
| Total Income | 10482 | 10671 | 10450.6 | 10394.5 | 9610.3 | 10143.5 | 10627.1 | 11893.5 | 12123.2 | 11485.2 |
| Total Expenditure | 9752.7 | 9690.9 | 9353 | 9038.1 | 8159.1 | 8473 | 8800.9 | 9995.3 | 10078.1 | 9289.6 |
| Other Income | 15.6 | 81.9 | 76.7 | 105.5 | 101.2 | 98.3 | 102 | 124 | 125.5 | 133.1 |
| Operating Profit | 729.3 | 980.1 | 1097.6 | 1356.4 | 1451.2 | 1670.5 | 1826.2 | 1898.2 | 2045.1 | 2195.6 |
| Interest | 126 | 199.3 | 201.8 | 131.6 | 131.1 | 159.2 | 211.7 | 135.2 | 129 | 112.5 |
| Exceptional Items | -300 | |||||||||
| PBDT | 603.3 | 480.8 | 895.8 | 1224.8 | 1320.1 | 1511.3 | 1614.5 | 1763 | 1916.1 | 2083.1 |
| Depreciation | 120.6 | 125.4 | 122.9 | 117.7 | 115.7 | 119.1 | 121.9 | 120.8 | 123.7 | 124.9 |
| Profit Before Tax | 482.7 | 355.4 | 772.9 | 1107.1 | 1204.4 | 1392.2 | 1492.6 | 1642.2 | 1792.4 | 1958.2 |
| Tax | 93.4 | 64.1 | 142.6 | 339.9 | 327.8 | 383.8 | 413.7 | 496.1 | 557.9 | 613.8 |
| Profit After Tax | 389.3 | 291.3 | 630.3 | 767.2 | 876.6 | 1008.4 | 1078.9 | 1146.1 | 1234.5 | 1344.4 |
| Net Profit | 389.3 | 291.3 | 630.3 | 767.2 | 876.6 | 1008.4 | 1078.9 | 1146.1 | 1234.5 | 1344.4 |
| Equity Capital | 419.3 | 419.3 | 419.4 | 432.7 | 439 | 440 | 440.7 | 492.6 | 493.5 | 493.7 |
| Face Value (IN RS) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Calculated EPS | 0.93 | 0.69 | 1.5 | 1.77 | 2 | 2.29 | 2.45 | 2.33 | 2.5 | 2.72 |
| Diluted Eps After Extraordinary Items | 0.93 | 0.69 | 1.51 | 1.81 | 2.02 | 2.3 | 2.45 | 2.39 | 2.5 | 2.7 |
| Diluted Eps Before Extraordinary Items | 0.93 | 0.69 | 1.51 | 1.81 | 2.02 | 2.3 | 2.45 | 2.39 | 2.5 | 2.7 |
CONSOLIDATED ANNUAL RESULT FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 27913.2 | 41718.4 | 41848.9 |
| Total Income | 27985.4 | 41998.1 | 42274.1 |
| Total Expenditure | 26352.5 | 37726.4 | 35398.2 |
| Other Income | 72.2 | 279.7 | 425.2 |
| Operating Profit | 1632.9 | 4271.7 | 6875.9 |
| Interest | 356.2 | 660.7 | 638.7 |
| Exceptional Items | -246.5 | -300 | |
| PBDT | 1030.2 | 3311 | 6237.2 |
| Depreciation | 495.5 | 508.5 | 498.6 |
| Profit Before Tax | 534.7 | 2802.5 | 5738.6 |
| Tax | 144.2 | 643.9 | 1631.8 |
| Profit After Tax | 390.5 | 2158.6 | 4106.8 |
| Net Profit | 390.5 | 2158.6 | 4106.8 |
| Equity Capital | 419 | 432.7 | 492.6 |
| Face Value (IN RS) | 1 | 1 | 1 |
| Reserves | 18257.4 | 22372.3 | 29963.2 |
| Calculated EPS | 0.98 | 4.99 | 8.34 |
| Diluted Eps After Extraordinary Items | 0.98 | 5.13 | 9.16 |
| Diluted Eps Before Extraordinary Items | 0.98 | 5.13 | 9.16 |
STANDALONE ANNUAL RESULT FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 27913.1 | 41718.4 | 41848.9 |
| Total Income | 27985.3 | 41998.1 | 42274.4 |
| Total Expenditure | 26373.9 | 37834.7 | 35428.3 |
| Other Income | 72.2 | 279.7 | 425.5 |
| Operating Profit | 1611.4 | 4163.4 | 6846.1 |
| Interest | 350.4 | 658.7 | 637.2 |
| Exceptional Items | -300 | ||
| PBDT | 1261 | 3204.7 | 6208.9 |
| Depreciation | 466.3 | 486.6 | 477.5 |
| Profit Before Tax | 794.7 | 2718.1 | 5731.4 |
| Tax | 144.1 | 640 | 1621.4 |
| Profit After Tax | 650.6 | 2078.1 | 4110 |
| Net Profit | 650.6 | 2078.1 | 4110 |
| Equity Capital | 419 | 432.7 | 492.6 |
| Face Value (IN RS) | 1 | 1 | 1 |
| Reserves | 17618.8 | 21723.3 | 29319.5 |
| Calculated EPS | 1.55 | 4.8 | 8.34 |
| Diluted Eps After Extraordinary Items | 1.55 | 4.94 | 9.16 |
| Diluted Eps Before Extraordinary Items | 1.55 | 4.94 | 9.16 |
CONSOLIDATED PROFIT / LOSS FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 1679.46 Cr | 2791.32 Cr | 4171.84 Cr | 4184.89 Cr |
| Sales | 1668.49 Cr | 2773.3 Cr | 4152.26 Cr | 4160.74 Cr |
| Net Sales | 1679.46 Cr | 2791.32 Cr | 4171.84 Cr | 4184.89 Cr |
| Increase/Decrease in Stock | 151.83 Cr | -139.68 Cr | -30.14 Cr | -36.7 Cr |
| Raw Material Consumed | 1082.09 Cr | 2384.54 Cr | 3284.54 Cr | 3066.98 Cr |
| Opening Raw Materials | 95.47 Cr | 181.66 Cr | 481.49 Cr | 221.54 Cr |
| Purchases Raw Materials | 1170.76 Cr | 2684.36 Cr | 3024.59 Cr | 3186.08 Cr |
| Closing Raw Materials | 181.66 Cr | 481.49 Cr | 221.54 Cr | 340.64 Cr |
| Power & Fuel Cost | 12.6 Cr | 16.86 Cr | 15.96 Cr | 12.87 Cr |
| Electricity & Power | 12.6 Cr | 16.86 Cr | 15.96 Cr | 12.87 Cr |
| Employee Cost | 76.11 Cr | 80.77 Cr | 91.51 Cr | 110.48 Cr |
| Salaries, Wages & Bonus | 66.39 Cr | 69.16 Cr | 77.19 Cr | 91.43 Cr |
| Contributions to EPF & Pension Funds | 3.12 Cr | 3.47 Cr | 4.36 Cr | 5.54 Cr |
| Workmen and Staff Welfare Expenses | 5.29 Cr | 7.08 Cr | 9.15 Cr | 12.57 Cr |
| Other Manufacturing Expenses | 27.58 Cr | 45.42 Cr | 41.55 Cr | 40.24 Cr |
| Repairs and Maintenance | 22.36 Cr | 35.29 Cr | 35.33 Cr | 31.15 Cr |
| General and Administration Expenses | 26.64 Cr | 35.71 Cr | 55.46 Cr | 64.14 Cr |
| Rent , Rates & Taxes | 5.08 Cr | 4.72 Cr | 7.78 Cr | 18.62 Cr |
| Insurance | 4.29 Cr | 4.68 Cr | 5.42 Cr | 6.06 Cr |
| Selling and Distribution Expenses | 119.56 Cr | 153.15 Cr | 215.08 Cr | 195.31 Cr |
| Sales Commissions & Incentives | 11.06 Cr | 12.59 Cr | 15.04 Cr | 14.83 Cr |
| Freight and Forwarding | 108.5 Cr | 140.56 Cr | 200.03 Cr | 180.48 Cr |
| Miscellaneous Expenses | 52.13 Cr | 58.48 Cr | 98.69 Cr | 86.52 Cr |
| Provision for doubtful debts | 3 Cr | 0 | 0 | 1.83 Cr |
| Loss on foreign exchange fluctuations | 0 | 6.81 Cr | 19.8 Cr | -9.69 Cr |
| Total Expenditure | 1548.53 Cr | 2635.26 Cr | 3772.65 Cr | 3539.83 Cr |
| Other Income | 14.05 Cr | 7.22 Cr | 27.97 Cr | 42.52 Cr |
| Interest Received | 4.64 Cr | 2.75 Cr | 17.58 Cr | 36.15 Cr |
| Profits on sale of Investments | 9.33 Lk | 0 | 0 | 0 |
| Foreign Exchange Gains | 5.21 Cr | 0 | 0 | 0 |
| Operating Profit | 144.97 Cr | 163.28 Cr | 427.17 Cr | 687.58 Cr |
| Interest | 33.43 Cr | 35.62 Cr | 66.07 Cr | 63.87 Cr |
| Bank Charges etc | 1.86 Cr | 4.12 Cr | 3.59 Cr | 2.94 Cr |
| PBDT | 111.54 Cr | 127.66 Cr | 361.1 Cr | 623.72 Cr |
| Depreciation | 46.97 Cr | 49.55 Cr | 50.85 Cr | 49.86 Cr |
| Profit Before Taxation & Exceptional Items | 64.56 Cr | 78.12 Cr | 310.25 Cr | 573.86 Cr |
| Exceptional Income / Expenses | 0 | -24.65 Cr | -30 Cr | 0 |
| Profit Before Tax | 64.56 Cr | 53.47 Cr | 280.25 Cr | 573.86 Cr |
| Provision for Tax | 17.3 Cr | 14.41 Cr | 64.39 Cr | 163.17 Cr |
| Current Income Tax | 11.84 Cr | 13.89 Cr | 47.84 Cr | 100.97 Cr |
| Deferred Tax | 5.45 Cr | 51.76 Lk | 16.55 Cr | 62.11 Cr |
| Profit After Tax | 47.27 Cr | 39.05 Cr | 215.86 Cr | 410.68 Cr |
| Minority Interest | 21.14 Lk | 1.89 Cr | 11.83 Lk | 8.98 Lk |
| Consolidated Net Profit | 47.48 Cr | 40.95 Cr | 215.98 Cr | 410.77 Cr |
| Profit Balance B/F | 1044.87 Cr | 1086.43 Cr | 1121.09 Cr | 1328.66 Cr |
| Appropriations | 1092.35 Cr | 1127.37 Cr | 1337.07 Cr | 1739.43 Cr |
| Other Appropriation | 5.92 Cr | 6.28 Cr | 8.41 Cr | 11.21 Cr |
| Equity Dividend % | 15 | 20 | 25 | 50 |
| Earnings Per Share | 1.13 | 0.98 | 4.99 | 8.34 |
| Adjusted EPS | 1.13 | 0.98 | 4.99 | 8.34 |
STANDALONE PROFIT / LOSS FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Gross Sales | 1679.46 Cr | 2791.31 Cr | 4171.84 Cr | 4184.89 Cr |
| Sales | 1668.49 Cr | 2773.3 Cr | 4152.26 Cr | 4160.74 Cr |
| Net Sales | 1679.46 Cr | 2791.31 Cr | 4171.84 Cr | 4184.89 Cr |
| Increase/Decrease in Stock | 83.62 Cr | -141.78 Cr | -30.14 Cr | -36.7 Cr |
| Raw Material Consumed | 1156.46 Cr | 2391.8 Cr | 3297.28 Cr | 3071.85 Cr |
| Opening Raw Materials | 94.8 Cr | 181.05 Cr | 482.38 Cr | 222.56 Cr |
| Purchases Raw Materials | 1245.19 Cr | 2693.13 Cr | 3037.47 Cr | 3193.49 Cr |
| Closing Raw Materials | 181.05 Cr | 482.38 Cr | 222.56 Cr | 344.21 Cr |
| Power & Fuel Cost | 9.58 Cr | 11.63 Cr | 11.57 Cr | 9.14 Cr |
| Electricity & Power | 9.58 Cr | 11.63 Cr | 11.57 Cr | 9.14 Cr |
| Employee Cost | 75.51 Cr | 80.16 Cr | 90.95 Cr | 109.97 Cr |
| Salaries, Wages & Bonus | 65.85 Cr | 68.69 Cr | 76.74 Cr | 90.98 Cr |
| Contributions to EPF & Pension Funds | 3.12 Cr | 3.47 Cr | 4.36 Cr | 5.54 Cr |
| Workmen and Staff Welfare Expenses | 5.23 Cr | 6.95 Cr | 9.04 Cr | 12.51 Cr |
| Other Manufacturing Expenses | 30.57 Cr | 50.38 Cr | 45.91 Cr | 43.93 Cr |
| Repairs and Maintenance | 23.79 Cr | 37.42 Cr | 37.3 Cr | 32.47 Cr |
| General and Administration Expenses | 26.33 Cr | 35.34 Cr | 55.08 Cr | 63.74 Cr |
| Rent , Rates & Taxes | 4.91 Cr | 4.54 Cr | 7.59 Cr | 18.43 Cr |
| Insurance | 4.29 Cr | 4.68 Cr | 5.42 Cr | 6.06 Cr |
| Selling and Distribution Expenses | 119.48 Cr | 152.68 Cr | 214.86 Cr | 195.32 Cr |
| Sales Commissions & Incentives | 11.06 Cr | 12.59 Cr | 15.04 Cr | 14.83 Cr |
| Freight and Forwarding | 108.42 Cr | 140.09 Cr | 199.82 Cr | 180.5 Cr |
| Miscellaneous Expenses | 50.33 Cr | 57.19 Cr | 97.97 Cr | 95.28 Cr |
| Provision for doubtful debts | 0 | 0 | 0 | 1.83 Cr |
| Loss on foreign exchange fluctuations | 0 | 7.67 Cr | 19.8 Cr | 0 |
| Total Expenditure | 1551.89 Cr | 2637.39 Cr | 3783.47 Cr | 3552.53 Cr |
| Other Income | 13.83 Cr | 7.22 Cr | 27.97 Cr | 52.24 Cr |
| Interest Received | 4.64 Cr | 2.75 Cr | 17.58 Cr | 36.21 Cr |
| Profits on sale of Investments | 9.33 Lk | 0 | 0 | 0 |
| Foreign Exchange Gains | 4.99 Cr | 0 | 0 | 9.69 Cr |
| Operating Profit | 141.4 Cr | 161.14 Cr | 416.34 Cr | 684.6 Cr |
| Interest | 33.21 Cr | 35.04 Cr | 65.88 Cr | 63.72 Cr |
| Bank Charges etc | 1.81 Cr | 3.7 Cr | 3.54 Cr | 2.91 Cr |
| PBDT | 108.19 Cr | 126.1 Cr | 350.47 Cr | 620.88 Cr |
| Depreciation | 44.22 Cr | 46.63 Cr | 48.66 Cr | 47.75 Cr |
| Profit Before Taxation & Exceptional Items | 63.97 Cr | 79.47 Cr | 301.81 Cr | 573.14 Cr |
| Exceptional Income / Expenses | 0 | 0 | -30 Cr | 0 |
| Profit Before Tax | 63.97 Cr | 79.47 Cr | 271.81 Cr | 573.14 Cr |
| Provision for Tax | 17.3 Cr | 14.4 Cr | 64 Cr | 162.14 Cr |
| Current Income Tax | 11.84 Cr | 13.89 Cr | 47.46 Cr | 100.04 Cr |
| Deferred Tax | 5.45 Cr | 51.76 Lk | 16.55 Cr | 62.11 Cr |
| Profit After Tax | 46.67 Cr | 65.06 Cr | 207.81 Cr | 411 Cr |
| Consolidated Net Profit | 46.67 Cr | 65.06 Cr | 207.81 Cr | 411 Cr |
| Profit Balance B/F | 939.92 Cr | 980.67 Cr | 1039.45 Cr | 1238.85 Cr |
| Appropriations | 986.59 Cr | 1045.73 Cr | 1247.26 Cr | 1649.85 Cr |
| Other Appropriation | 5.92 Cr | 6.28 Cr | 8.41 Cr | 11.21 Cr |
| Equity Dividend % | 15 | 20 | 25 | 50 |
| Earnings Per Share | 1.11 | 1.55 | 4.8 | 8.34 |
| Adjusted EPS | 1.11 | 1.55 | 4.8 | 8.34 |
CONSOLIDATED CASH FLOW FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 64.56 Cr | 53.47 Cr | 280.25 Cr | 573.86 Cr |
| Adjustment | 82.96 Cr | 124.85 Cr | 98.96 Cr | 75.39 Cr |
| Changes In working Capital | -174.33 Cr | 169.83 Cr | -277.84 Cr | -151.64 Cr |
| Cash Flow after changes in Working Capital | -26.81 Cr | 348.14 Cr | 101.37 Cr | 497.61 Cr |
| Cash Flow from Operating Activities | -40.41 Cr | 330.88 Cr | 53.96 Cr | 404.76 Cr |
| Cash Flow from Investing Activities | -113.56 Cr | -28.23 Cr | -396.66 Cr | -404.86 Cr |
| Cash Flow from Financing Activitie | 164.66 Cr | -181.98 Cr | 377.12 Cr | 7.19 Cr |
| Net Cash Inflow / Outflow | 10.69 Cr | 120.67 Cr | 34.41 Cr | 7.08 Cr |
| Opening Cash & Cash Equivalents | 42.03 Cr | 52.72 Cr | 173.38 Cr | 207.8 Cr |
| Effect of Foreign Exchange Fluctuations | -65,000 | -2,000 | 46,000 | 2,000 |
| Closing Cash & Cash Equivalent | 52.72 Cr | 173.38 Cr | 207.8 Cr | 214.88 Cr |
STANDALONE CASH FLOW FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 63.97 Cr | 79.47 Cr | 271.81 Cr | 573.14 Cr |
| Adjustment | 82.61 Cr | 98.8 Cr | 103.69 Cr | 70.86 Cr |
| Changes In working Capital | -172.23 Cr | 168.9 Cr | -274.84 Cr | -151.68 Cr |
| Cash Flow after changes in Working Capital | -25.66 Cr | 347.17 Cr | 100.66 Cr | 492.32 Cr |
| Cash Flow from Operating Activities | -39.26 Cr | 329.91 Cr | 53.25 Cr | 400.35 Cr |
| Cash Flow from Investing Activities | -113.46 Cr | -28.23 Cr | -396.6 Cr | -405.12 Cr |
| Cash Flow from Financing Activitie | 165.56 Cr | -180.67 Cr | 378.1 Cr | 8.12 Cr |
| Net Cash Inflow / Outflow | 12.85 Cr | 121.02 Cr | 34.75 Cr | 3.35 Cr |
| Opening Cash & Cash Equivalents | 37.44 Cr | 50.28 Cr | 171.29 Cr | 206.05 Cr |
| Effect of Foreign Exchange Fluctuations | -65,000 | -2,000 | 46,000 | 2,000 |
| Closing Cash & Cash Equivalent | 50.28 Cr | 171.29 Cr | 206.05 Cr | 209.4 Cr |
CONSOLIDATED BALANCE SHEET FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 41.9 Cr | 41.9 Cr | 43.27 Cr | 49.26 Cr |
| Equity - Authorised | 70.01 Cr | 70.01 Cr | 70.01 Cr | 70.01 Cr |
| Equity - Issued | 41.9 Cr | 41.9 Cr | 43.27 Cr | 49.26 Cr |
| Equity Paid Up | 41.9 Cr | 41.9 Cr | 43.27 Cr | 49.26 Cr |
| Face Value | 1 | 1 | 1 | 1 |
| Total Reserves | 1747.5 Cr | 1821.92 Cr | 2130.87 Cr | 2995.08 Cr |
| Securities Premium | 456 Cr | 456 Cr | 549.7 Cr | 967.59 Cr |
| Capital Reserves | 12.8 Cr | 12.8 Cr | 12.8 Cr | 12.8 Cr |
| Profit & Loss Account Balance | 1086.43 Cr | 1121.09 Cr | 1328.66 Cr | 1728.23 Cr |
| General Reserves | 189.56 Cr | 189.56 Cr | 189.56 Cr | 189.56 Cr |
| Reserve excluding Revaluation Reserve | 1747.5 Cr | 1821.92 Cr | 2130.87 Cr | 2995.08 Cr |
| Shareholder's Funds | 1792.91 Cr | 1867.64 Cr | 2280.51 Cr | 3045.58 Cr |
| Minority Interest | -68.69 Lk | -2.69 Cr | -2.81 Cr | -2.79 Cr |
| Secured Loans | 84.39 Cr | 93.17 Cr | 48.31 Cr | 21.54 Cr |
| Term Loans - Banks | 123.09 Cr | 130.64 Cr | 92.2 Cr | 31.17 Cr |
| Deferred Tax Assets / Liabilities | 61.79 Cr | 73.16 Cr | 93.96 Cr | 169.13 Cr |
| Deferred Tax Assets | 171.32 Cr | 188.4 Cr | 180.29 Cr | 122.82 Cr |
| Deferred Tax Liability | 233.1 Cr | 261.56 Cr | 274.25 Cr | 291.96 Cr |
| Other Long Term Liabilities | 7.32 Cr | 5.85 Cr | 4.68 Cr | 3.35 Cr |
| Long Term Provisions | 250.09 Cr | 264.3 Cr | 265.86 Cr | 316.25 Cr |
| Total Non-Current Liabilities | 403.6 Cr | 436.48 Cr | 412.81 Cr | 510.28 Cr |
| Trade Payables | 152.91 Cr | 778.6 Cr | 345.59 Cr | 570.36 Cr |
| Sundry Creditors | 148.51 Cr | 349.05 Cr | 342.43 Cr | 563.07 Cr |
| Acceptances | 4.4 Cr | 429.55 Cr | 3.15 Cr | 7.29 Cr |
| Other Current Liabilities | 92.81 Cr | 186.32 Cr | 158.73 Cr | 57.2 Cr |
| Advances received from customers | 8.99 Cr | 40.71 Cr | 59.9 Cr | 13.68 Cr |
| Interest Accrued But Not Due | 1.78 Cr | 3.39 Cr | 6.72 Cr | 4.08 Cr |
| Short Term Borrowings | 593.93 Cr | 445.85 Cr | 742.72 Cr | 565.7 Cr |
| Secured ST Loans repayable on Demands | 463.93 Cr | 330.85 Cr | 729.67 Cr | 565.7 Cr |
| Working Capital Loans- Sec | 463.93 Cr | 330.85 Cr | 729.67 Cr | 565.7 Cr |
| Short Term Provisions | 1.62 Cr | 1.62 Cr | 47.98 Cr | 102.07 Cr |
| Provision for Tax | 0 | 74,000 | 47.85 Cr | 100.97 Cr |
| Total Current Liabilities | 841.27 Cr | 1412.38 Cr | 1295.01 Cr | 1295.34 Cr |
| Total Liabilities | 3037.08 Cr | 3713.8 Cr | 3985.51 Cr | 4848.4 Cr |
| Gross Block | 2066.07 Cr | 2219.13 Cr | 2223.22 Cr | 2288.31 Cr |
| Less: Accumulated Depreciation | 598.32 Cr | 673.59 Cr | 708.08 Cr | 754.34 Cr |
| Net Block | 1467.75 Cr | 1545.53 Cr | 1515.14 Cr | 1533.98 Cr |
| Capital Work in Progress | 159.61 Cr | 76.55 Cr | 93.53 Cr | 66.52 Cr |
| Non Current Investments | 66.05 Cr | 113.32 Cr | 131.91 Cr | 476.72 Cr |
| Long Term Investment | 66.05 Cr | 113.32 Cr | 131.91 Cr | 476.72 Cr |
| Quoted | 5.1 Cr | 5.78 Cr | 6.08 Cr | 9.47 Cr |
| Unquoted | 60.95 Cr | 107.54 Cr | 125.83 Cr | 467.25 Cr |
| Long Term Loans & Advances | 294.92 Cr | 308.99 Cr | 312.42 Cr | 371.84 Cr |
| Other Non Current Assets | 1.33 Cr | 1.29 Cr | 49,000 | 60,000 |
| Total Non-Current Assets | 1989.66 Cr | 2045.68 Cr | 2053.01 Cr | 2449.07 Cr |
| Currents Investments | 0 | 0 | 0 | 82.23 Lk |
| Quoted | 0 | 0 | 0 | 82.23 Lk |
| Unquoted | 60.95 Cr | 107.54 Cr | 125.83 Cr | 467.25 Cr |
| Inventories | 339.4 Cr | 771.51 Cr | 544.22 Cr | 702.52 Cr |
| Raw Materials | 181.66 Cr | 481.49 Cr | 221.54 Cr | 340.64 Cr |
| Work-in Progress | 33.36 Cr | 91.25 Cr | 66.77 Cr | 84.76 Cr |
| Finished Goods | 78.89 Cr | 160.75 Cr | 215.38 Cr | 234.08 Cr |
| Packing Materials | 6.79 Cr | 7.14 Cr | 7.58 Cr | 8.3 Cr |
| Stores and Spare | 38.69 Cr | 30.88 Cr | 32.95 Cr | 34.73 Cr |
| Sundry Debtors | 461.45 Cr | 505.03 Cr | 504.89 Cr | 655.65 Cr |
| Debtors more than Six months | 0 | 19.07 Cr | 6.67 Cr | 8.47 Cr |
| Debtors Others | 468.62 Cr | 493.14 Cr | 505.4 Cr | 656.18 Cr |
| Cash and Bank | 137.71 Cr | 265.01 Cr | 624.8 Cr | 731.41 Cr |
| Cash in hand | 64.41 Lk | 65.59 Lk | 63.91 Lk | 53.82 Lk |
| Balances at Bank | 137.06 Cr | 264.36 Cr | 624.16 Cr | 730.87 Cr |
| Other Current Assets | 10.05 Cr | 10.16 Cr | 24.81 Cr | 35.14 Cr |
| Interest accrued on Investments | 96.23 Lk | 75.58 Lk | 13.78 Cr | 16.78 Cr |
| Prepaid Expenses | 2.94 Cr | 2.94 Cr | 0 | 0 |
| Short Term Loans and Advances | 98.82 Cr | 116.41 Cr | 233.78 Cr | 273.79 Cr |
| Advances recoverable in cash or in kind | 79.62 Cr | 103.14 Cr | 165.51 Cr | 154.19 Cr |
| Advance income tax and TDS | 0 | 0 | 47.41 Cr | 92.36 Cr |
| Total Current Assets | 1047.42 Cr | 1668.12 Cr | 1932.5 Cr | 2399.33 Cr |
| Net Current Assets (Including Current Investments) | 206.16 Cr | 255.74 Cr | 637.49 Cr | 1103.99 Cr |
| Total Assets | 3037.08 Cr | 3713.8 Cr | 3985.51 Cr | 4848.4 Cr |
| Contingent Liabilities | 151.12 Cr | 151.52 Cr | 135.48 Cr | 55.78 Cr |
| Total Debt | 719.09 Cr | 578.38 Cr | 836.2 Cr | 600.42 Cr |
| Book Value | 42.71 | 44.49 | 50.25 | 61.8 |
| Adjusted Book Value | 42.71 | 44.49 | 50.25 | 61.8 |
STANDALONE BALANCE SHEET FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 41.9 Cr | 41.9 Cr | 43.27 Cr | 49.26 Cr |
| Equity - Authorised | 70.01 Cr | 70.01 Cr | 70.01 Cr | 70.01 Cr |
| Equity - Issued | 41.9 Cr | 41.9 Cr | 43.27 Cr | 49.26 Cr |
| Equity Paid Up | 41.9 Cr | 41.9 Cr | 43.27 Cr | 49.26 Cr |
| Face Value | 1 | 1 | 1 | 1 |
| Total Reserves | 1662.87 Cr | 1758.06 Cr | 2065.96 Cr | 2930.72 Cr |
| Securities Premium | 456 Cr | 456 Cr | 549.7 Cr | 967.59 Cr |
| Capital Reserves | 12.8 Cr | 12.8 Cr | 12.8 Cr | 12.8 Cr |
| Profit & Loss Account Balance | 980.67 Cr | 1039.45 Cr | 1238.85 Cr | 1638.64 Cr |
| General Reserves | 189.56 Cr | 189.56 Cr | 189.56 Cr | 189.56 Cr |
| Reserve excluding Revaluation Reserve | 1662.87 Cr | 1758.06 Cr | 2065.96 Cr | 2930.72 Cr |
| Shareholder's Funds | 1708.28 Cr | 1803.78 Cr | 2215.6 Cr | 2981.21 Cr |
| Secured Loans | 84.39 Cr | 93.17 Cr | 48.31 Cr | 21.54 Cr |
| Term Loans - Banks | 123.09 Cr | 130.64 Cr | 92.2 Cr | 31.17 Cr |
| Deferred Tax Assets / Liabilities | 61.79 Cr | 73.16 Cr | 93.96 Cr | 169.13 Cr |
| Deferred Tax Assets | 171.32 Cr | 188.4 Cr | 180.29 Cr | 122.82 Cr |
| Deferred Tax Liability | 233.1 Cr | 261.56 Cr | 274.25 Cr | 291.96 Cr |
| Other Long Term Liabilities | 2.89 Cr | 1.86 Cr | 1.48 Cr | 1.06 Cr |
| Long Term Provisions | 250.09 Cr | 264.3 Cr | 265.86 Cr | 316.25 Cr |
| Total Non-Current Liabilities | 399.16 Cr | 432.49 Cr | 409.61 Cr | 507.99 Cr |
| Trade Payables | 149.02 Cr | 774.28 Cr | 341.04 Cr | 544.92 Cr |
| Sundry Creditors | 144.62 Cr | 344.74 Cr | 337.89 Cr | 537.63 Cr |
| Acceptances | 4.4 Cr | 429.55 Cr | 3.15 Cr | 7.29 Cr |
| Other Current Liabilities | 91.89 Cr | 185.33 Cr | 157.74 Cr | 56.26 Cr |
| Advances received from customers | 8.99 Cr | 40.71 Cr | 59.9 Cr | 13.68 Cr |
| Interest Accrued But Not Due | 1.78 Cr | 3.39 Cr | 6.72 Cr | 4.08 Cr |
| Short Term Borrowings | 593.93 Cr | 445.85 Cr | 742.72 Cr | 565.7 Cr |
| Secured ST Loans repayable on Demands | 463.93 Cr | 330.85 Cr | 729.67 Cr | 565.7 Cr |
| Working Capital Loans- Sec | 463.93 Cr | 330.85 Cr | 729.67 Cr | 565.7 Cr |
| Short Term Provisions | 1.62 Cr | 1.61 Cr | 47.58 Cr | 101.14 Cr |
| Provision for Tax | 0 | 0 | 47.46 Cr | 100.04 Cr |
| Total Current Liabilities | 836.45 Cr | 1407.08 Cr | 1289.09 Cr | 1268.02 Cr |
| Total Liabilities | 2943.9 Cr | 3643.35 Cr | 3914.3 Cr | 4757.22 Cr |
| Gross Block | 1947.85 Cr | 2093.64 Cr | 2096.39 Cr | 2166.42 Cr |
| Less: Accumulated Depreciation | 567.54 Cr | 613.32 Cr | 644.32 Cr | 690.95 Cr |
| Net Block | 1380.31 Cr | 1480.33 Cr | 1452.08 Cr | 1475.47 Cr |
| Capital Work in Progress | 159.61 Cr | 76.55 Cr | 93.53 Cr | 66.52 Cr |
| Non Current Investments | 66.05 Cr | 113.32 Cr | 131.91 Cr | 476.75 Cr |
| Long Term Investment | 66.05 Cr | 113.32 Cr | 131.91 Cr | 476.75 Cr |
| Quoted | 5.1 Cr | 5.78 Cr | 6.08 Cr | 9.47 Cr |
| Unquoted | 113.39 Cr | 159.99 Cr | 178.28 Cr | 519.73 Cr |
| Long Term Loans & Advances | 294.92 Cr | 308.99 Cr | 312.42 Cr | 372.89 Cr |
| Other Non Current Assets | 1.33 Cr | 1.29 Cr | 49,000 | 60,000 |
| Total Non-Current Assets | 1902.22 Cr | 1980.47 Cr | 1989.94 Cr | 2391.64 Cr |
| Unquoted | 113.39 Cr | 159.99 Cr | 178.28 Cr | 519.73 Cr |
| Inventories | 334.82 Cr | 772.4 Cr | 545.24 Cr | 706.09 Cr |
| Raw Materials | 181.05 Cr | 482.38 Cr | 222.56 Cr | 344.21 Cr |
| Work-in Progress | 33.37 Cr | 91.25 Cr | 66.77 Cr | 84.76 Cr |
| Finished Goods | 76.85 Cr | 160.75 Cr | 215.38 Cr | 234.08 Cr |
| Packing Materials | 6.68 Cr | 7.14 Cr | 7.58 Cr | 8.3 Cr |
| Stores and Spare | 36.86 Cr | 30.88 Cr | 32.95 Cr | 34.73 Cr |
| Sundry Debtors | 461.45 Cr | 505.03 Cr | 504.89 Cr | 655.65 Cr |
| Debtors more than Six months | 0 | 19.07 Cr | 6.67 Cr | 8.47 Cr |
| Debtors Others | 454.28 Cr | 478.8 Cr | 505.4 Cr | 656.18 Cr |
| Cash and Bank | 135.27 Cr | 262.92 Cr | 623.04 Cr | 725.93 Cr |
| Cash in hand | 64.27 Lk | 65.57 Lk | 62.19 Lk | 50.86 Lk |
| Balances at Bank | 134.62 Cr | 262.27 Cr | 622.42 Cr | 725.42 Cr |
| Other Current Assets | 9.91 Cr | 10.11 Cr | 24.78 Cr | 35.15 Cr |
| Interest accrued on Investments | 96.23 Lk | 75.58 Lk | 13.78 Cr | 16.78 Cr |
| Prepaid Expenses | 2.8 Cr | 2.88 Cr | 0 | 0 |
| Short Term Loans and Advances | 100.24 Cr | 112.41 Cr | 226.39 Cr | 242.76 Cr |
| Advances recoverable in cash or in kind | 94.99 Cr | 112.76 Cr | 171.36 Cr | 136.86 Cr |
| Advance income tax and TDS | 0 | 0 | 47.41 Cr | 91.96 Cr |
| Total Current Assets | 1041.68 Cr | 1662.87 Cr | 1924.35 Cr | 2365.58 Cr |
| Net Current Assets (Including Current Investments) | 205.22 Cr | 255.8 Cr | 635.27 Cr | 1097.56 Cr |
| Total Assets | 2943.9 Cr | 3643.35 Cr | 3914.3 Cr | 4757.22 Cr |
| Contingent Liabilities | 151.12 Cr | 151.52 Cr | 135.48 Cr | 55.78 Cr |
| Total Debt | 719.09 Cr | 578.38 Cr | 836.2 Cr | 600.42 Cr |
| Book Value | 40.69 | 42.96 | 48.75 | 0 |
| Adjusted Book Value | 40.69 | 42.96 | 48.75 | 60.5 |
FINANCIAL RATIOS (CONSOLIDATED) FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 1.13 | 0.98 | 4.99 | 8.34 |
| CEPS(Rs) | 2.25 | 2.11 | 6.16 | 9.35 |
| DPS(Rs) | 0.15 | 0.2 | 0.25 | 0.5 |
| Book NAV/Share(Rs) | 42.71 | 44.49 | 50.25 | 61.8 |
| Tax Rate(%) | 26.79 | 26.95 | 22.98 | 28.43 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 7.8 | 5.59 | 9.57 | 15.41 |
| EBIT Margin(%) | 5.83 | 3.19 | 8.3 | 15.24 |
| Pre Tax Margin(%) | 3.84 | 1.92 | 6.72 | 13.71 |
| PAT Margin (%) | 2.81 | 1.4 | 5.17 | 9.81 |
| Cash Profit Margin (%) | 5.61 | 3.17 | 6.39 | 11 |
| Performance Ratios | ||||
| ROA(%) | 1.62 | 1.16 | 5.61 | 9.3 |
| ROE(%) | 2.69 | 2.14 | 10.69 | 15.74 |
| ROCE(%) | 4.13 | 3.59 | 12.45 | 18.86 |
| Asset Turnover(x) | 0.58 | 0.83 | 1.08 | 0.95 |
| Sales/Fixed Asset(x) | 0.82 | 1.3 | 1.88 | 1.86 |
| Working Capital/Sales(x) | 8.15 | 10.91 | 6.54 | 3.79 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 1.22 | 0.77 | 0.53 | 0.54 |
| Receivable days | 82.7 | 63.19 | 44.18 | 50.61 |
| Inventory Days | 80.91 | 72.63 | 57.56 | 54.37 |
| Payable days | 28.06 | 40.45 | 38.78 | 54.53 |
| Valuation Parameters | ||||
| PER(x) | 36.8 | 76.08 | 17.5 | 36.17 |
| PCE(x) | 18.54 | 35.16 | 14.17 | 32.26 |
| Price/Book(x) | 0.98 | 1.67 | 1.74 | 4.88 |
| Yield(%) | 0.36 | 0.27 | 0.29 | 0.17 |
| EV/Net Sales(x) | 1.39 | 1.23 | 0.96 | 3.52 |
| EV/Core EBITDA(x) | 16.06 | 21 | 9.34 | 21.42 |
| EV/EBIT(x) | 23.76 | 38.48 | 11.53 | 23.09 |
| EV/CE(x) | 0.77 | 0.92 | 1 | 4.04 |
| M Cap / Sales | 1.04 | 1.12 | 0.91 | 3.55 |
| Growth Ratio | ||||
| Net Sales Growth(%) | -7 | 66.2 | 49.46 | 0.31 |
| Core EBITDA Growth(%) | -49.72 | 12.63 | 161.61 | 60.96 |
| EBIT Growth(%) | -60.65 | -9.09 | 288.76 | 84.14 |
| PAT Growth(%) | -76.98 | -17.37 | 452.71 | 90.25 |
| EPS Growth(%) | -76.9 | -13.76 | 410.72 | 67.07 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.4 | 0.31 | 0.38 | 0.2 |
| Current Ratio(x) | 1.25 | 1.18 | 1.49 | 1.85 |
| Quick Ratio(x) | 0.84 | 0.63 | 1.07 | 1.31 |
| Interest Cover(x) | 2.93 | 2.5 | 5.24 | 9.99 |
| Total Debt/Mcap(x) | 0.41 | 0.19 | 0.22 | 0.04 |
FINANCIAL RATIOS (STANDALONE) FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 1.11 | 1.55 | 4.8 | 8.34 |
| CEPS(Rs) | 2.17 | 2.67 | 5.93 | 9.31 |
| DPS(Rs) | 0.15 | 0.2 | 0.25 | 0.5 |
| Book NAV/Share(Rs) | 40.69 | 42.96 | 48.75 | 60.5 |
| Tax Rate(%) | 27.04 | 18.13 | 23.55 | 28.29 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | 7.6 | 5.51 | 9.31 | 15.11 |
| EBIT Margin(%) | 5.79 | 4.1 | 8.09 | 15.22 |
| Pre Tax Margin(%) | 3.81 | 2.85 | 6.52 | 13.7 |
| PAT Margin (%) | 2.78 | 2.33 | 4.98 | 9.82 |
| Cash Profit Margin (%) | 5.41 | 4 | 6.15 | 10.96 |
| Performance Ratios | ||||
| ROA(%) | 1.66 | 1.98 | 5.5 | 9.48 |
| ROE(%) | 2.78 | 3.71 | 10.63 | 16.15 |
| ROCE(%) | 4.24 | 4.76 | 12.43 | 19.2 |
| Asset Turnover(x) | 0.6 | 0.85 | 1.1 | 0.97 |
| Sales/Fixed Asset(x) | 0.87 | 1.38 | 1.99 | 1.96 |
| Working Capital/Sales(x) | 8.18 | 10.91 | 6.57 | 3.81 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 1.15 | 0.72 | 0.5 | 0.51 |
| Receivable days | 82.7 | 63.19 | 44.18 | 50.61 |
| Inventory Days | 72.41 | 72.39 | 57.64 | 54.57 |
| Payable days | 24.14 | 39.69 | 38.13 | 52.64 |
| Valuation Parameters | ||||
| PER(x) | 37.43 | 47.88 | 18.19 | 36.15 |
| PCE(x) | 19.22 | 27.89 | 14.74 | 32.39 |
| Price/Book(x) | 1.02 | 1.73 | 1.79 | 4.99 |
| Yield(%) | 0.36 | 0.27 | 0.29 | 0.17 |
| EV/Net Sales(x) | 1.39 | 1.23 | 0.96 | 3.52 |
| EV/Core EBITDA(x) | 16.48 | 21.29 | 9.59 | 21.52 |
| EV/EBIT(x) | 23.99 | 29.96 | 11.83 | 23.14 |
| EV/CE(x) | 0.79 | 0.94 | 1.02 | 4.11 |
| M Cap / Sales | 1.04 | 1.12 | 0.91 | 3.55 |
| Growth Ratio | ||||
| Net Sales Growth(%) | -6.88 | 66.2 | 49.46 | 0.31 |
| Core EBITDA Growth(%) | -51.06 | 13.96 | 158.38 | 64.43 |
| EBIT Growth(%) | -21.81 | 17.83 | 194.91 | 88.59 |
| PAT Growth(%) | -42.36 | 39.4 | 219.4 | 97.78 |
| EPS Growth(%) | -42.39 | 39.4 | 209.26 | 73.73 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.42 | 0.32 | 0.4 | 0.2 |
| Current Ratio(x) | 1.25 | 1.18 | 1.49 | 1.87 |
| Quick Ratio(x) | 0.85 | 0.63 | 1.07 | 1.31 |
| Interest Cover(x) | 2.93 | 3.27 | 5.13 | 9.99 |
| Total Debt/Mcap(x) | 0.41 | 0.19 | 0.22 | 0.04 |
SHARE HOLDING PATTERN FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| Date | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 45.39 | 45.39 | 45.38 | 45.62 | 44.96 | 44.86 | 44.79 | 50.29 | 50.20 | 50.78 |
| FII % | 1.61 | 1.97 | 2.38 | 2.36 | 2.96 | 5.12 | 5.39 | 5.13 | 5.16 | 5.24 |
| DII % | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.07 | 0.10 | 0.13 | 0.13 | 0.02 |
| Public % | 53.00 | 52.63 | 51.74 | 51.54 | 51.54 | 49.52 | 49.18 | 42.46 | 42.37 | 40.40 |
PEER COMPARISON FOR HIMADRI SPECIALITY CHEMICAL LIMITED
CORPORATE ACTIONS FOR HIMADRI SPECIALITY
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 09-Oct-2024 | Board Meeting - Quarterly Results | 16-Oct-2024 |
| BSE 09-Jul-2024 | Board Meeting - Quarterly Results | 16-Jul-2024 |
| BSE 24-May-2024 | Book Closure - Rs.0.5000 per share(50%)Final Dividend & A.G.M. | 08-Jun-2024 20-Jun-2024 |
| BSE 24-May-2024 | AGM - Rs.0.5000 per share(50%)Final Dividend & A.G.M. | 20-Jun-2024 20-Jun-2024 |
| BSE 25-Apr-2024 | Dividend - Rs.0.5000 per share(50%)Final Dividend | |
| BSE 18-Apr-2024 | Board Meeting - Quarterly Results & Final Dividend & Audited Results | 25-Apr-2024 |
| BSE 22-Mar-2024 | SAST - Pursuant to Regulation 30 of SEBI(LODR) Regulations, 2015 we would like to inform you that the Board of Directors at its meeting held on 20.03.2024 inter-aliahas considered and approved the acquisition of 40% equity shares of Invati Creations Private Limited. | |
| BSE 15-Mar-2024 | Board Meeting - Inter-alia to consider and approve the following:- 1. Proposal for issuance of equity shares by way of preferential allotment in accordance with the applicable law, subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company; 2. Proposal for raising of funds by way of issuance of equity shares / preference shares / bonds / debentures / warrants... | 20-Mar-2024 |
| BSE 09-Jan-2024 | Board Meeting - Quarterly Results | 16-Jan-2024 |
| BSE 06-Dec-2023 | SAST - Pursuant to Regulation 30 of SEBI Listing Regulations, this is to inform you that Himadri Clean Energy Limited, the WOS has informed the Company that it hasproposed to acquire 100% shareholdings of Himadri Future Material Technology Limited to make it WOS. On completion of above acquisition Himadri Future MaterialTechnology Limited will become a step down WOS of the Company. | |
| BSE 18-Oct-2023 | SAST - Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, this is to inform you that the Board at its meeting held today on 17 October 2023, inter-alia has considered and approved acquisition of 100% equity shares of Himadri Clean Energy Limited. | |
| BSE 10-Oct-2023 | Board Meeting - Quarterly Results | 17-Oct-2023 |
| BSE 20-Jul-2023 | SAST - In continuation of our earlier announcement dated 18 July 2023 and pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, this is to inform you that the Company has completed acquisition of 100% Equity Shares of Combe Projects Private Limited. Consequent to the said acquisition, Combe Projects Private Limited has become Wholly Owned Subsidiary of the Company w.e.f 20 July 2023. | |
| BSE 11-Jul-2023 | Board Meeting - Quarterly Results | 18-Jul-2023 |
| BSE 24-May-2023 | Book Closure - Rs.0.2500 per share(25%)Final Dividend & A.G.M. | 10-Jun-2023 22-Jun-2023 |
| BSE 24-May-2023 | AGM - Rs.0.2500 per share(25%)Final Dividend & A.G.M. | 22-Jun-2023 22-Jun-2023 |
| BSE 28-Apr-2023 | Dividend - Rs.0.2500 per share(25%)Final Dividend | |
| BSE 21-Apr-2023 | Board Meeting - Final Dividend & Audited Results | 28-Apr-2023 |
| BSE 03-Feb-2023 | Board Meeting - Quarterly Results | 10-Feb-2023 |
| BSE 21-Oct-2022 | Board Meeting - Quarterly Results | 29-Oct-2022 |
| BSE 02-Sep-2022 | Book Closure - Rs.0.2000 per share(20%)Final Dividend & A.G.M. | 22-Sep-2022 28-Sep-2022 |
| BSE 02-Sep-2022 | AGM - Rs.0.2000 per share(20%)Final Dividend & A.G.M. | 28-Sep-2022 28-Sep-2022 |
| BSE 03-Aug-2022 | Board Meeting - Quarterly Results | 11-Aug-2022 |
| BSE 21-Jul-2022 | Dividend - Rs.0.2000 per share(20%)Final Dividend | |
| BSE 15-Jul-2022 | Board Meeting - Final Dividend & Audited Results | 21-Jul-2022 |
| BSE 11-Jul-2022 | Board Meeting - Inter-alia to consider and evaluate proposal for raising of funds by the Company in one or more tranches through one or more permissible mechanisms as may be deemed appropriate by the Board, by way of issuance of equity shares and / or other securities including share warrants convertible into Equity shares of the Company and / or any other equity based instruments / securities including through p... | 14-Jul-2022 |
| BSE 04-Feb-2022 | Board Meeting - Quarterly Results | 11-Feb-2022 |
| BSE 03-Nov-2021 | Board Meeting - Quarterly Results | 12-Nov-2021 |
CORPORATE ANNOUNCEMENTS FOR HIMADRI SPECIALITY
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 28-Oct-2024 | General Announcements FILE | Submission Of Certificate From Statutory Auditor In Terms Of Regulation 169(5) Of The Securities And Exchange Board Of India (Issue Of Capital And Disclosure Requirements) Regulations 2018 Pursuant to Regulation 169(5) of SEBI ICDR Regulations please find enclosed certificate issued by Statutory Auditor. |
| BSE 22-Oct-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to regulation 39(3) of the SEBI (LODR) Regulations 2015 intimation is hereby given that the following share certificate(s) has/have been reported as lost by the shareholders. |
| BSE 21-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment Allotment of 25 000 equity shares pursuant to exercise of Warrants allotted on preferential basis. |
| BSE 18-Oct-2024 | General Announcements FILE | Certificate Regarding Redemption Of Commercial Paper Certificate regarding redemption of Commercial Paper amounting to Rs 50 Crores |
| BSE 16-Oct-2024 | General Announcements FILE | Compliance Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Six Months Ended 30 September 2024 Related party transactions disclosure for the six months ended 30 September 2024. |
| BSE 16-Oct-2024 | Compliance FILE | Statement Of Deviation Or Variation In The Use Of Proceeds Of Allotment Of Equity Shares Pursuant To Exercise Of Warrants Allotted On Preferential Basis Statement of deviation or variation in the use of proceeds of allotment of Equity Shares pursuant to exercise of warrants allotted on preferential basis |
| BSE 16-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Monitoring Agency Report Monitoring Agency Report for the quarter ended 30 September 2024 |
| BSE 16-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Media/ Press Release |
| BSE 16-Oct-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Investor Presentation Investor Presentation on the financial results for the quarter ended 30 September 2024 |
| BSE 16-Oct-2024 | Outcome FILE | Board Meeting Outcome for Outcome Of Board Meeting Held On 16.10.2024 We would like to inform you that the Board at its meeting held today i.e. on 16 October 2024 inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six-months ended 30 September 2024. |
| BSE 16-Oct-2024 | Outcome FILE | Financial Results For The Quarter And Six-Months Ended 30 September 2024 Financial Results for the quarter and six- months ended 30 September 2024 |
| BSE 09-Oct-2024 | Intimation FILE | Board Meeting Intimation for Notice Of Board Meeting Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2024 inter alia to consider and approve Notice pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI (LODR) Regulations 2015) is hereby given that a meeting of the Board of Directors (Board) of Himadri Speciality Chemical Ltd (Company) will be held on Wednesday 16 October 2024 inter-alia to approve and take on record the Un-audited Standalone and ConsolidatedFinancial Results for quarter and six months ended 30 September 2024. |
| BSE 07-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 75(5) of SEBI (Depositories & Participants) Regulations 2018 |
| BSE 24-Sep-2024 | Intimation FILE | Closure of Trading Window The Trading Window to deal with securities of the Company will remain closed for all Designated Persons (including their immediate relatives) from 01 October 2024 till 48 hours after the declaration of un-audited financial results for the quarter and half year ended 30.09.2024. |
| BSE 23-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Change in Directorate Completion of tenure of Independent Director |
| BSE 19-Sep-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of the SEBI (LODR)Regulation 2015 intimation is hereby given that the Company on 18 September 2024 has issued Duplicate Share Certificates of 7770 equity shares of Re.1/- each in lieu of the original share certificates reported lost/misplaced. |
| BSE 13-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the Listing Regulations we would like to inform you that the officials of Himadri Speciality Chemical Ltd will be having one-on-one and/or group meeting with Analysts/ Investors through video conference on 18 September 2024. |
| BSE 13-Sep-2024 | General Announcements FILE | Submission Of Certificate From Statutory Auditor In Terms Of Regulation 169(5) Of The SEBI (ICDR) Regulations 2018 Pursuant to Regulation 169(5) of the ICDR Regulations please find enclosed certificate issued by Statutory Auditors. |
| BSE 11-Sep-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of the SEBI (LODR) Regulations 2015 intimation is hereby given that the share certificate (s) has/have been reported as lost by the shareholder. |
| BSE 09-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment Allotment of 34 000 Equity Shares pursuant to exercise of Warrants allotted on preferential basis. |
| BSE 31-Aug-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of the SEBI (LODR) Regulations 2015 intimation is hereby given that the share certificate (s) has/have been reported as lost by shareholders. |
| BSE 29-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Allotment Allotment of Equity Shares pursuant to Himadri Employee Stock Option Plan 2016 |
| BSE 22-Aug-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of the SEBI Regulations 2015 intimation is hereby given that the following share certificate(s) has/have been reported as lost by the following shareholder. |
| BSE 21-Aug-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of the SEBI (LODR) regulation 2015 Intimation is hereby given that the Company on 20 August 2024 has issued Duplicate Share Certificates of 8000 equity shares of Re.1/- in lieu of the original share certificate reported lost/misplaced to the shareholders. |
| BSE 19-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we would like to inform you that the officials of Himadri Speciality Chemical Limited (Company) will be having one-on-one and/or group meetings with Analysts/Investors through calls/video conference/in person meetings on 23 August 2024. |
| BSE 08-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we would like to inform you that the officials of Himadri Speciality Chemical Limited (Company) will be having one-on-one and/or group meetings with Analysts/Investors through calls/video conference/in person meetings on 13th and 14th August 2024. |
| BSE 08-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we would like to inform you that the officials of Himadri Speciality Chemical Limited (Company) will be having one-on-one and/or group meetings with Analysts/Investors through calls/video conference/in person meetings on 13th and 14th August 2024. |
| BSE 07-Aug-2024 | General Announcements FILE | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of the SEBI (LODR) Regulations 2015 intimation is hereby given that the following share certificate (s) has/have been reported as lost by the shareholders. |
| BSE 06-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we would like to inform you that the officials of Himadri Speciality Chemical Limited (Company) will be having one-on-one and/or group meetings with Analysts/Investors through calls/video conference/in person meetings on 9 August 2024. |
| BSE 01-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Updates on Acquisition Acquisition of 100% equity shares of Himadri Green Technologies Innovation Limited to make it a Wholly Owned Step -down Subsidiary |
INSIDER TRADING FOR HIMADRI SPECIALITY
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 21-Apr-2022 21-Apr-2022 | Buy ESOP | 56,818 @ 0.00 (0.00 %) | Soumen Chakraborty |
| BSE 21-Apr-2022 21-Apr-2022 | Buy ESOP | 65,000 @ 0.00 (0.00 %) | Kamlesh Kumar Agarwal |
BULK BLOCK DEALS FOR HIMADRI SPECIALITY CHEMICAL LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 21-Oct-2021 | Sell BULK | 3,500,000 @ 51.77 | BC INDIA INVESTMENTS |
| BSE 18-Oct-2021 | Sell BULK | 5,000,000 @ 51.01 | BC INDIA INVESTMENTS |
DIVIDEND BY HIMADRI SPECIALITY CHEMICAL LIMITED
| Ex Dividend Date | Dividend Type | Dividend |
|---|---|---|
| 07-Jun-2024 | DIVIDEND | 0.5 |
| 09-Jun-2023 | DIVIDEND | 0.25 |
| 20-Sep-2022 | DIVIDEND | 0.2 |
| 21-Sep-2021 | DIVIDEND | 0.15 |
SPLIT / BONUS BY HIMADRI SPECIALITY CHEMICAL LIMITED
No Split / Bonus details found
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed
